250 related articles for article (PubMed ID: 12828747)
1. Kinetics of the superficial perfusion and temperature in connection with photodynamic therapy of basal cell carcinomas using esterified and non-esterified 5-aminolaevulinic acid.
Pålsson S; Gustafsson L; Bendsoe N; Soto Thompson M; Andersson-Engels S; Svanberg K
Br J Dermatol; 2003 Jun; 148(6):1179-88. PubMed ID: 12828747
[TBL] [Abstract][Full Text] [Related]
2. Superficial blood flow following photodynamic therapy of malignant non-melanoma skin tumours measured by laser Doppler perfusion imaging.
Wang I; Andersson-Engels S; Nilsson GE; Wårdell K; Svanberg K
Br J Dermatol; 1997 Feb; 136(2):184-9. PubMed ID: 9068729
[TBL] [Abstract][Full Text] [Related]
3. Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial.
de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ; de Haas ER
Acta Derm Venereol; 2012 Nov; 92(6):641-7. PubMed ID: 22964973
[TBL] [Abstract][Full Text] [Related]
4. Topical 5-aminolevulinic acid mediated photodynamic therapy of superficial basal cell carcinoma using two light fractions with a two-hour interval: long-term follow-up.
Star WM; van't Veen AJ; Robinson DJ; Munte K; de Haas ER; Sterenborg HJ
Acta Derm Venereol; 2006; 86(5):412-7. PubMed ID: 16955185
[TBL] [Abstract][Full Text] [Related]
5. Kinetic fluorescence studies of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation in basal cell carcinomas.
af Klinteberg C; Enejder AM; Wang I; Andersson-Engels S; Svanberg S; Svanberg K
J Photochem Photobiol B; 1999 Apr; 49(2-3):120-8. PubMed ID: 10392462
[TBL] [Abstract][Full Text] [Related]
6. The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy.
Choudry K; Brooke RC; Farrar W; Rhodes LE
Br J Dermatol; 2003 Jul; 149(1):124-30. PubMed ID: 12890205
[TBL] [Abstract][Full Text] [Related]
7. Topical photodynamic therapy at low fluence rates--theory and practice.
Langmack K; Mehta R; Twyman P; Norris P
J Photochem Photobiol B; 2001 Apr; 60(1):37-43. PubMed ID: 11386679
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy using topical 5-aminolaevulinic acid vs. surgery for basal cell carcinoma.
Cosgarea R; Susan M; Crisan M; Senila S
J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):980-4. PubMed ID: 22738399
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy.
Fink-Puches R; Soyer HP; Hofer A; Kerl H; Wolf P
Arch Dermatol; 1998 Jul; 134(7):821-6. PubMed ID: 9681345
[TBL] [Abstract][Full Text] [Related]
10. Treatment of superficial basal cell carcinoma with photodynamic therapy. Observational study in 22 patients with 5-aminolaevulinic acid and methyl aminolaevulinate.
Alique-García S; Company-Quiroga J; Sánchez Campos A; Hernández Núñez A; Borbujo J
Photodiagnosis Photodyn Ther; 2019 Jun; 26():190-192. PubMed ID: 30914392
[TBL] [Abstract][Full Text] [Related]
11. Treatment of superficial basal cell carcinoma by topical photodynamic therapy with fractionated 5-aminolaevulinic acid 20% vs. two-stage topical methyl aminolaevulinate: results of a randomized controlled trial.
Kessels JPHM; Kreukels H; Nelemans PJ; Roozeboom MH; van Pelt H; Mosterd K; de Haas ERM; Kelleners-Smeets NWJ
Br J Dermatol; 2018 May; 178(5):1056-1063. PubMed ID: 28886209
[TBL] [Abstract][Full Text] [Related]
12. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
[TBL] [Abstract][Full Text] [Related]
13. Temperature monitoring during photodynamic therapy of skin tumors with topical 5-aminolevulinic acid application.
Orenstein A; Kostenich G; Tsur H; Kogan L; Malik Z
Cancer Lett; 1995 Jul; 93(2):227-32. PubMed ID: 7621433
[TBL] [Abstract][Full Text] [Related]
14. Plum-blossom needling enhanced the effect of photodynamic therapy on basal cell carcinoma.
Mu X; Wang L; Wang L; Ge R; Dang H; Mou K
Photodiagnosis Photodyn Ther; 2018 Sep; 23():339-341. PubMed ID: 30077651
[TBL] [Abstract][Full Text] [Related]
15. Delta-aminolevulinic acid in superficial basal cell carcinomas and normal skin-a microdialysis and perfusion study.
Wennberg AM; Larkö O; Lönnroth P; Larson G; Krogstad AL
Clin Exp Dermatol; 2000 Jun; 25(4):317-22. PubMed ID: 10971495
[TBL] [Abstract][Full Text] [Related]
16. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group.
Morton CA; Brown SB; Collins S; Ibbotson S; Jenkinson H; Kurwa H; Langmack K; McKenna K; Moseley H; Pearse AD; Stringer M; Taylor DK; Wong G; Rhodes LE
Br J Dermatol; 2002 Apr; 146(4):552-67. PubMed ID: 11966684
[TBL] [Abstract][Full Text] [Related]
17. Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma.
Campbell SM; Morton CA; Alyahya R; Horton S; Pye A; Curnow A
Br J Dermatol; 2008 Aug; 159(2):387-93. PubMed ID: 18544077
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of topical 5-aminolaevulinic acid photodynamic therapy diode laser single session for non-melanoma skin cancer.
Souza CS; Felicio LB; Ferreira J; Kurachi C; Bentley MV; Tedesco AC; Bagnato VS
Photodiagnosis Photodyn Ther; 2009; 6(3-4):207-13. PubMed ID: 19932453
[TBL] [Abstract][Full Text] [Related]
19. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome.
Itkin A; Gilchrest BA
Dermatol Surg; 2004 Jul; 30(7):1054-61. PubMed ID: 15209801
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy of superficial basal cell carcinomas using topical 5-aminolevulinic acid in a nanocolloid lotion.
Hürlimann AF; Hänggi G; Panizzon RG
Dermatology; 1998; 197(3):248-54. PubMed ID: 9812030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]